Newron Pharmaceuticals SpA (NWRN) — Cash Flow-to-Debt Ratio
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of CHF-1.33 Million could theoretically repay 0% of its total liabilities (CHF51.15 Million) in one year. Explore Newron Pharmaceuticals SpA long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Newron Pharmaceuticals SpA Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Newron Pharmaceuticals SpA across 21 annual periods. Also explore Newron Pharmaceuticals SpA assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Newron Pharmaceuticals SpA (2005–2025)
Year-by-year debt coverage analysis for Newron Pharmaceuticals SpA. For market capitalisation and broader financial context, see Newron Pharmaceuticals SpA stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | CHF32.56 Million | CHF51.15 Million | ▲ +325.7% |
| 2024 | -0.28x | CHF-17.61 Million | CHF62.45 Million | ▼ -55.1% |
| 2023 | -0.18x | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.09 Million | CHF51.23 Million | ▲ +10.4% |
| 2021 | -0.24x | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.94x | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.09x | CHF-15.95 Million | CHF5.16 Million | ▼ -95.0% |
| 2017 | -1.58x | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.86x | CHF-19.58 Million | CHF6.84 Million | ▼ -61.7% |
| 2015 | -1.77x | CHF-12.86 Million | CHF7.27 Million | ▼ -38.3% |
| 2014 | -1.28x | CHF-10.00 Million | CHF7.81 Million | ▼ -26.1% |
| 2013 | -1.02x | CHF-10.69 Million | CHF10.53 Million | ▼ -396.9% |
| 2012 | 0.34x | CHF5.83 Million | CHF17.04 Million | ▲ +148.3% |
| 2011 | -0.71x | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.76x | CHF-19.13 Million | CHF6.94 Million | ▼ -48.1% |
| 2009 | -1.86x | CHF-23.06 Million | CHF12.39 Million | ▼ -37.5% |
| 2008 | -1.35x | CHF-19.93 Million | CHF14.73 Million | ▼ -26.6% |
| 2007 | -1.07x | CHF-13.87 Million | CHF12.97 Million | ▼ -103.2% |
| 2006 | -0.53x | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.21x | CHF-14.33 Million | CHF6.48 Million | — |